Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 31

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry

Rao, Ashwin, Rule, Jody A., Hameed, Bilal, Ganger, Daniel, Fontana, Robert J., Lee, William M. · 2022 · American Journal of Gastroenterology

Abstract

INTRODUCTION: Idiosyncratic drug-induced liver injury (DILI) is the second leading cause of acute liver failure (ALF) in the United States. Our study aims were to characterize secular trends in the implicated agents, clinical features, and outcomes of adults with DILI ALF over a 20-year period. METHODS: Among 2,332 patients with ALF enrolled in the ALF Study Group registry, 277 (11.9%) were adjudicated as idiosyncratic DILI ALF (INR ≥ 1.5 and hepatic encephalopathy) through expert opinion. The 155 cases in era 1 (January 20, 1998–January 20, 2008) were compared with the 122 cases in era 2 (January 21, 2008–January 20, 2018). RESULTS: Among 277 cases of DILI ALF, 97 different agents, alone or in combination, were implicated: antimicrobials, n = 118 (43%); herbal/dietary supplements (HDS), n = 42 (15%); central nervous system agents/illicit substances, n = 37 (13%); oncologic/biologic agents, n = 29 (10%); and other, n = 51 (18%). Significant trends over time included (i) an increase in HDS DILI ALF (9.7% vs 22%, P < 0.01) and decrease in antimicrobial-induced DILI ALF (45.8% vs. 38.5%, P = 0.03) and (ii) improved overall transplant-free survival (23.5%–38.7%, P < 0.01) while the number of patients transplanted declined (46.4% vs 33.6%, P < 0.03). DISCUSSION: DILI ALF in North America is evolving, with HDS cases rising and other categories of suspect drugs declining. The reasons for a significant increase in transplant-free survival and reduced need for liver transplantation over time remain unclear but may be due to improvements in critical care, increased NAC utilization, and improved patient prognostication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000001655

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 40

  1. Fontana, 2014, Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives, Gastroenterology, 146, 914, 10.1053/j.gastro.2013.12.032 · DOI · Paper page
  2. Hoofnagle, 2013, LiverTox: A website on drug-induced liver injury, Hepatology, 57, 873, 10.1002/hep.26175 · DOI · Paper page
  3. Sgro, 2002, Incidence of drug-induced hepatic injuries: A French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
  4. Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
  5. Russo, 2004, Liver transplantation for acute liver failure from drug induced liver injury in the United States, Liver Transpl, 10, 1018, 10.1002/lt.20204 · DOI · Paper page
  6. Wei, 2007, Acute liver failure in Sweden: Etiology and outcome, J Intern Med, 262, 393, 10.1111/j.1365-2796.2007.01818.x · DOI · Paper page
  7. Polson, 2005, AASLD position paper: The management of acute liver failure, Hepatology, 41, 1179, 10.1002/hep.20703 · DOI · Paper page
  8. Stravitz, 2011, Autoimmune acute liver failure: Proposed clinical and histological criteria, Hepatology, 53, 517, 10.1002/hep.24080 · DOI · Paper page
  9. Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
  10. Kamath, 2007, The model for end-stage liver disease (MELD), Hepatology, 45, 797, 10.1002/hep.21563 · DOI · Paper page
  11. Chalasani, 2015, Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study, Gastroenterology, 148, 1340, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
  12. Andrade, 2005, Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  13. Devarbhavi, 2010, Single-center experience with drug-induced liver injury from India: Causes, outcome, prognosis, and predictors of mortality, Am J Gastroenterol, 105, 2396, 10.1038/ajg.2010.287 · DOI · Paper page
  14. Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
  15. Waxman, 2009, Sex differences in the expression of hepatic drug metabolizing enzymes, Mol Pharmacol, 76, 215, 10.1124/mol.109.056705 · DOI · Paper page
  16. Zopf, 2009, Gender-based differences in drug prescription: Relation to adverse drug reactions, Pharmacology, 84, 333, 10.1159/000248311 · DOI
  17. Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 96, 10.1053/j.gastro.2014.03.045 · DOI · Paper page
  18. Hayashi, 2017, Death and liver transplantation within 2 years of onset of drug-induced liver injury, Hepatology, 66, 1275, 10.1002/hep.29283 · DOI · Paper page
  19. Chalasani, 2017, Idiosyncratic drug induced liver injury in African-Americans is associated with greater morbidity and mortality compared to Caucasians, Am J Gastroenterol, 112, 1382, 10.1038/ajg.2017.215 · DOI · Paper page
  20. Kleiner, 2014, Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI · Paper page
  21. Khan, 2018, Changes in tuberculosis disparities at a time of decreasing tuberculosis incidence in the United States, 1994-2016, Am J Public Health, 108, S321, 10.2105/AJPH.2018.304606 · doi:10.2105/ajph.2018.304606
  22. Avigan, 2016, Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States, Int J Mol Sci, 17, 331, 10.3390/ijms17030331 · DOI
  23. Bailey, 2011, Dietary supplement use in the United States, 2003-2006, J Nutr, 141, 261, 10.3945/jn.110.133025 · DOI · Paper page
  24. Fong, 2010, Hepatotoxicity due to hydroxycut: A case series, Am J Gastroenterol, 105, 1561, 10.1038/ajg.2010.5 · DOI
  25. Heidemann, 2016, Severe acute hepatocellular injury attributed to OxyELITE pro: A case series, Dig Dis Sci, 61, 2741, 10.1007/s10620-016-4181-7 · DOI
  26. Kesar, 2021, Liver transplantation for acute liver injury in Asians is more likely due to herbal and dietary supplements, Liver Transpl
  27. Ghabril, 2021, Eight fold increase in the dietary supplement related liver failure leading to transplant waitlisting over the last quarter century in the US, Liver Transpl
  28. Navarro, 2013, Catechins in dietary supplements and hepatotoxicity, Dig Dis Sci, 58, 2682, 10.1007/s10620-013-2687-9 · DOI
  29. Mehta, 2008, Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions, J Altern Complement Med, 14, 1263, 10.1089/acm.2008.0290 · DOI · Paper page
  30. Verma, 2007, Complementary and alternative medicine in hepatology: Review of the evidence of efficacy, Clin Gastroenterol Hepatol, 5, 408, 10.1016/j.cgh.2006.10.014 · DOI
  31. Beuchat, 2017, Newer antiepileptic drugs in status epilepticus: Prescription trends and outcomes in comparison with traditional agents, CNS Drugs, 31, 327, 10.1007/s40263-017-0424-1 · DOI
  32. Willems, 2018, Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013: A ten-year overview, Epilepsy Behav, 83, 28, 10.1016/j.yebeh.2018.03.025 · DOI
  33. Björnsson, 2016, Hepatotoxicity by drugs: The most common implicated agents, Int J Mol Sci, 17, 224, 10.3390/ijms17020224 · DOI · Paper page
  34. Hillman, 2016, Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury, Am J Gastroenterol, 111, 958, 10.1038/ajg.2016.114 · DOI
  35. Reuben, 2016, Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study, Ann Intern Med, 164, 724, 10.7326/M15-2211 · DOI · Paper page
  36. Lee, 2009, Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure, Gastroenterology, 137, 856, 10.1053/j.gastro.2009.06.006 · DOI · Paper page
  37. Garcia-Cortes, 2011, Causality assessment methods in drug induced liver injury: Strengths and weaknesses, J Hepatol, 55, 683, 10.1016/j.jhep.2011.02.007 · DOI · Paper page
  38. Danan, 2015, RUCAM in drug and herb induced liver injury: The update, Int J Mol Sci, 17, 14, 10.3390/ijms17010014 · DOI · Paper page
  39. Lucena, 2008, Assessment of drug-induced liver injury in clinical practice, Fundam Clin Pharmacol, 22, 141, 10.1111/j.1472-8206.2008.00566.x · DOI
  40. Mishra, 2021, Dietary supplement use among adults: United States, 2017-2018, NCHS Data Brief, 1

Cited by

See all 31

Metadata

Authors
Rao, A., Rule, J. A., Hameed, B., Ganger, D., Fontana, R. J., & Lee, W. M.
Affiliations
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA;
  • Division of Gastroenterology and Hepatology, University of California San Francisco School of Medicine, San Francisco, California, USA;
  • Division of Gastroenterology and Hepatology, Northwestern Medicine, Chicago, Illinois, USA;
  • Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Venue
American Journal of Gastroenterology
Published
2022-01-25
Volume
117
Issue
4
Pages
617-626
ISSN
  • 0002-9270
  • 1572-0241
Cited by
31
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry. https://app.cochat.ai/papers/10.14309/ajg.0000000000001655
The paper
Rao, A., Rule, J. A., Hameed, B., Ganger, D., Fontana, R. J., & Lee, W. M. (2022). Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000001655

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.